Liquid Biopsy Market Size $17.33 Billion by 2030
Report Overview:
The Global Liquid Biopsy Market achieved a valuation of $4.71 Billion in 2022 and is anticipated to exceed $17.33 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 17.7% during the forecast period from 2024 to 2032.
Key Market Players:
Bio-Rad Laboratories (U.S.), Biocept Inc. (U.S.), Guardant Health (U.S.), Illumina Inc. (U.S.), F....
0 Commentarii
0 Distribuiri